Literature DB >> 23196649

Oculoplastic aspects of ocular oncology.

C Rene1.   

Abstract

It is estimated that 5-10% of all cutaneous malignancies involve the periocular region and management of periocular skin cancers account for a significant proportion of the oculoplastic surgeon's workload. Epithelial tumours are most frequently encountered, including basal cell carcinoma, squamous cell carcinoma, and sebaceous gland carcinoma, in decreasing order of frequency. Non-epithelial tumours, such as cutaneous melanoma and Merkel cell carcinoma, rarely involve the ocular adnexae. Although non-surgical treatments for periocular malignancies are gaining in popularity, surgery remains the main treatment modality and has as its main aims tumour clearance, restoration of the eyelid function, protection of the ocular surface, and achieving a good cosmetic outcome. The purpose of this article is to review the management of malignant periocular tumours, with particular emphasis on surgical management.

Entities:  

Mesh:

Year:  2012        PMID: 23196649      PMCID: PMC3574244          DOI: 10.1038/eye.2012.243

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  71 in total

1.  Radiation treatment of cancer of the eyelids.

Authors:  M Lederman
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

2.  Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.

Authors:  Claudia Schiessl; Carola Wolber; Martina Tauber; Felix Offner; Robert Strohal
Journal:  J Drugs Dermatol       Date:  2007-05       Impact factor: 2.114

3.  Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.

Authors:  M K Silverman; A W Kopf; A H Gladstein; R S Bart; C M Grin; M J Levenstein
Journal:  J Dermatol Surg Oncol       Date:  1992-07

4.  Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.

Authors:  David Vidal; Xavier Matías-Guiu; Agustín Alomar
Journal:  Arch Dermatol       Date:  2007-02

5.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Treatment of eyelid carcinoma.

Authors:  A N Domonkos
Journal:  Arch Dermatol       Date:  1965-04

7.  Prognostic factors for survival in malignant melanoma of the eyelid skin.

Authors:  B Esmaeli; B Wang; M Deavers; A Gillenwater; H Goepfert; E Diaz; S Eicher
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-07       Impact factor: 1.746

8.  Is 2-mm punch biopsy useful in the diagnosis of malignant eyelid tumors?

Authors:  Rachel Camargo Carneiro; Erick Marcet Santiago de Macedo; Patricia Picciarelli de Lima; Rodolfo Bonatti; Suzana Matayoshi
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Jul-Aug       Impact factor: 1.746

9.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

10.  Nonsurgical treatment options for Basal cell carcinoma.

Authors:  Mary H Lien; Vernon K Sondak
Journal:  J Skin Cancer       Date:  2011-01-09
View more
  4 in total

Review 1.  Oral nicotinamide for non-melanoma skin cancers: A review.

Authors:  Samantha Vicki Hunt; Aaron Jamison; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

Review 2.  Applications of stem cell biology to oculoplastic surgery.

Authors:  Michael G Daniel; Albert Y Wu
Journal:  Curr Opin Ophthalmol       Date:  2016-09       Impact factor: 3.761

3.  Holding back the tears: is there a role for marsupialisation?

Authors:  Stephanie J Chiu; Zanna I Currie; Jennifer Hy Tan
Journal:  BMJ Open Ophthalmol       Date:  2022-08

Review 4.  Using stem cell biology to study and treat ophthalmologic and oculoplastic diseases.

Authors:  Albert Y Wu; Michael G Daniel
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.